Yosuke Yamakawa

2.0k citations
96 papers · 1.5k indexed · h-index 21
Topics
Myasthenia Gravis and Thymoma (25 papers)Tracheal and airway disorders (14 papers)Salivary Gland Tumors Diagnosis and Treatment (9 papers)
Partner nations
JapanUnited States

In The Last Decade

Yosuke Yamakawa

85 papers receiving 1.5k citations

Peers

Yosuke Yamakawa
Comparison fields: 5 of 91
  • Molecular Biology 574
  • Neurology 425
  • Oncology 347
  • Pulmonary and Respiratory Medicine 318
  • Surgery 310
Replace Ichiro Fukai with:
Ichiro Fukai Japan
Mamoru Ito Japan
Katsuhiro Nakagawa Japan
M Koss United States
Markus Raderer Austria
Masanobu Kiriyama Japan
Guido Seitz Germany
Kenji Inui Japan
Gabriella Bernini Italy
Stéphane Loyau France
Yosuke Yamakawa relative to Ichiro Fukai Japan Ichiro Fukai's profile →
Citations per field
00.5×1.5×
Ichiro Fukai · 1×
Citations per year

Countries citing papers authored by Yosuke Yamakawa

Since Specialization
Citations

This map shows the geographic impact of Yosuke Yamakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosuke Yamakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosuke Yamakawa more than expected).

Fields of papers citing papers by Yosuke Yamakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yosuke Yamakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosuke Yamakawa. The network helps show where Yosuke Yamakawa may publish in the future.

Co-authorship network of co-authors of Yosuke Yamakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yosuke Yamakawa. A scholar is included among the top collaborators of Yosuke Yamakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yosuke Yamakawa. Yosuke Yamakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 20
2 7
3 3
4 7
5 26
6 10
7 27
8 62
9 5
10 6
11 1
12 4
13 14
14 1
15 14
16 6
17 13
18 56
19 10
20 25

About Yosuke Yamakawa

Yosuke Yamakawa is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Genetics, having authored 96 papers that have together received 1.5k indexed citations. Recurring topics across this work include Myasthenia Gravis and Thymoma (25 papers), Tracheal and airway disorders (14 papers) and Salivary Gland Tumors Diagnosis and Treatment (9 papers). The work is most often cited by research in Neurology (425 citations), Oncology (347 citations) and Cancer Research (169 citations). Yosuke Yamakawa has collaborated with scholars based in Japan and United States. Frequent co-authors include Ichiro Fukai, Masanobu Kiriyama, Yoshitaka Fujii, Hidefumi Sasaki, Akira Masaoka, Yoshihiro Kobayashi, Yoshiaki Nakashima, Hiroshi Niwa, Haruhiro Yukiue and Satoru Moriyama. Their work appears in journals such as Cancer, Brain Research and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026